Enzo Offers Shares to Lawyers to Pay Legal Fees | GenomeWeb

NEW YORK (GenomeWeb News) – Enzo Biochem has issued 275,000 shares of its common stock to its law firm as payment for legal fees, the New York-based company disclosed in a document filed on Friday with the US Securities and Exchange Commission.

In its SEC document Enzo said that the offering, which closed on June 27, was made to pay $500,000 it owed its legal counsel Greenberg Traurig. Based on the $1.73 closing price of Enzo's stock on June 26, the aggregate value of the shares issued in the offering was $475,750, Enzo said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.